Considerable progress has been made in the development of anticancer agents over the
past few decades, and a lot of new anticancer agents from natural and synthetic sources …

Tumour angiogenesis is the formation of new blood vessels to support the growth of a
tumour. This process is critical for tumour progression and metastasis, making it an attractive …

Angiogenesis is the process of generating new blood vessels from pre-existing vasculature.
Under normal conditions, this process is delicately controlled by pro-angiogenic and anti …

Cancer is one of the leading causes of death. Globally a huge number of deaths and new
incidences are reported annually. Heterocyclic compounds have been proved to be very …

COVID-19 has modified the way we practice medicine. For thyroid cancer, there have been
several significant impacts. First, the diagnosis has been delayed due to social isolation …

Vascular endothelial growth factors (VEGF), Vascular endothelial growth factor receptors
(VEGFR) and their downstream signaling pathways are promising targets in anti-angiogenic …

Thyroid carcinomas (TCs), the most common endocrine tumors, represent the eighth most
common cancer diagnosed worldwide in both women and men. To treat these malignancies …

Since their introduction around a decade ago, embolic drug-eluting beads (DEBs) have
become a well-established treatment option for the locoregional transarterial treatment of …

Cancer is a disease characterized by genetic or epigenetic alterations in somatic cells that
result in uncontrolled cell growth and spread to other regions of the body. They are one type …

In a minority of differentiated thyroid cancer (TC) cases and in a large percentage of poorly
differentiated TCs (PDTCs) and anaplastic TCs (ATCs), the prognosis is poor due to the lack …